Covered recipient · General Payments record
ROBERTO A MORAN
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2022–2024
$2,639.06
- Reported across 55 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,817.81 | 36 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $431.83 | 7 |
| Novo Nordisk AS | $376.58 | 10 |
| Amgen Inc. | $357.19 | 4 |
| IBSA Pharma Inc. | $196.43 | 5 |
| Esperion Therapeutics, Inc. | $151.45 | 2 |
| IRONWOOD PHARMACEUTICALS, INC | $125.00 | 1 |
| Ardelyx, Inc. | $83.32 | 3 |
| Cumberland Pharmaceuticals, Inc. | $53.85 | 2 |
| PFIZER INC. | $25.09 | 1 |
| Merck Sharp & Dohme Corporation | $17.07 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (36)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $18.34 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105063846 | CMS |
| ABBVIE INC. | $5.76 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105063848 | CMS |
| ABBVIE INC. | $125.00 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105063850 | CMS |
| ABBVIE INC. | $17.84 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105063852 | CMS |
| ABBVIE INC. | $120.92 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105063854 | CMS |
| ABBVIE INC. | $12.68 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105063856 | CMS |
| ABBVIE INC. | $131.29 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105063858 | CMS |
| Amgen Inc. | $124.99 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115944274 | CMS |
| Amgen Inc. | $125.00 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117633843 | CMS |
| Amgen Inc. | $22.44 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117633815 | CMS |
| Amgen Inc. | $84.76 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117633817 | CMS |
| Ardelyx, Inc. | $32.14 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146696480 | CMS |
| Ardelyx, Inc. | $24.66 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146696482 | CMS |
| Ardelyx, Inc. | $26.52 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146696484 | CMS |
| Cumberland Pharmaceuticals, Inc. | $24.32 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146402407 | CMS |
| Cumberland Pharmaceuticals, Inc. | $29.53 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146402409 | CMS |
| Esperion Therapeutics, Inc. | $124.83 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1129447556 | CMS |
| Esperion Therapeutics, Inc. | $26.62 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1129447558 | CMS |
| IBSA Pharma Inc. | $24.63 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142980543 | CMS |
| IBSA Pharma Inc. | $23.88 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142980545 | CMS |
| IBSA Pharma Inc. | $124.55 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142977200 | CMS |
| IBSA Pharma Inc. | $17.80 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142980547 | CMS |
| IBSA Pharma Inc. | $5.57 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142980549 | CMS |
| IRONWOOD PHARMACEUTICALS, INC | $125.00 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153749730 | CMS |
| Merck Sharp & Dohme LLC | $17.07 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141938055 | CMS |
| Novo Nordisk Inc | $23.41 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096607273 | CMS |
| Novo Nordisk Inc | $19.30 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096568466 | CMS |
| Novo Nordisk Inc | $121.83 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096625498 | CMS |
| Novo Nordisk Inc | $8.44 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096795931 | CMS |
| Novo Nordisk Inc | $19.24 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097110379 | CMS |
| Novo Nordisk Inc | $9.89 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096682559 | CMS |
| Novo Nordisk Inc | $7.40 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097620027 | CMS |
| Novo Nordisk Inc | $124.39 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096929202 | CMS |
| Novo Nordisk Inc | $20.08 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097321106 | CMS |
| Novo Nordisk Inc | $22.60 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097477127 | CMS |
| PFIZER INC. | $25.09 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131463458 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.